Kehua Biotech announced that Suzhou Tianlong Biotechnology Co., Ltd., a holding subsidiary of the company, recently received a medical device registration certificate issued by the State Drug Administration. The product is a norovirus type GI and GII nucleic acid typing test kit. The registration certificate is valid from October 09, 2026 to October 8, 2031, to qualitatively test norovirus type GI and GII nucleic acid RNA in fecal samples. The acquisition of this registration certificate has enriched the company's product line and had a positive impact on the company's business development.

Kehua Biotech announced that Suzhou Tianlong Biotechnology Co., Ltd., a holding subsidiary of the company, recently received a medical device registration certificate issued by the State Drug Administration. The product is a norovirus type GI and GII nucleic acid typing test kit. The registration certificate is valid from October 09, 2026 to October 8, 2031, to qualitatively test norovirus type GI and GII nucleic acid RNA in fecal samples. The acquisition of this registration certificate has enriched the company's product line and had a positive impact on the company's business development.